BRISBANE, Calif., Dec. 18, 2025 /PRNewswire/ — CUTERA, INC., a leading provider in aesthetic, dermatological solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted expanded indications for its truFlex muscle stimulation technology. This expanded clearance moves truFlex beyond aesthetic use alone, adding rehabilitative and therapeutic applications and opening new treatment areas for the arms and calves.

“The new truFlex indications reflect a major advancement in how we approach muscle rehabilitation and functional strength. Its precision and customization make it an exceptional modality for supporting patients at every stage of their wellness and rehabilitation journey. I’m energized by what this means for my patients and the meaningful impact it will have in my practice,” said Dr. Edward Alvarez, CEO and Founder of Restimulate Health.